Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alfonso, Berrocal Jaime"'
Autor:
María Martínez-García, Sonia Servitja Tormo, Noelia Vilariño Quintela, Ana Arance Fernández, Alfonso Berrocal Jaime, Blanca Cantos Sánchez de Ibargüen, Sonia Del Barco Berrón, Rosario García Campelo, Regina Gironés Sarrió, Juan Manuel Sepúlveda-Sánchez
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately 25% of
Autor:
Teresa Curiel, J.M. Piulats, Salvador Martín-Algarra, Montserrat Gomà, Miriam Redrado, Luis Merino, Alfonso Berrocal-Jaime, Mar Varela, Rafael López Castro, Lorenzo Alonso Carrión, Alfonso Calvo González, Enrique Espinosa, Delvys Rodriguez-Abreu, Antonio Rullan
Publikováno v:
Journal of Clinical Oncology. 39:586-598
PURPOSE This study aimed to assess the efficacy of the combination of nivolumab (nivo) plus ipilimumab (ipi) as a first-line therapy with respect to the 12-month overall survival (OS) in patients with metastatic uveal melanoma (MUM) who are not eligi
Autor:
Pablo Cerezuela-Fuentes, María González-Cao, Antonio Piñero-Madrona, Sebastián Ortiz-Reina, Enrique Espinosa-Arranz, Eva Muñoz-Couselo, José Luis Manzano-Mozo, Iván Márquez-Rodas, Teresa Puértolas-Hernández, Salvador Martín-Algarra, Ainara Soria-Rivas, Alfonso Berrocal-Jaime
Publikováno v:
Medicina. 42:707-721
Considerables avances se han vivido en los últimos años, tanto en el conocimiento de la biología del melanoma como en el desarrollo de nuevas terapias médicas que han acreditado ser muy activas, capaces no sólo de inducir respuestas clínicas y
Autor:
María Dolores López Alarcón, Manuel Hernández Peris, Jorge Pastor Peidro, Carlos Ferrer Albiach, Ana Blasco Cordellat, Almudena Ruiz Sastre, Francisco Villegas Estévez, Alfonso Berrocal Jaime, Vicente Domingo Triado, Genoveva Hernández Comes, José López Torrecilla, Pilar Blasco Segura
Publikováno v:
Open Journal of Pain Medicine. 3:008-014
Objective: Breakthrough cancer pain (BTcP) is still underestimated and a percentage of patients are not adequately treated, affecting their quality of life. The aim of this review was to generate a series of expert recommendations based on clinical e
Publikováno v:
Melanoma research. 31(2)
Pembrolizumab is a treatment that has shown a survival benefit in patients with metastatic melanoma. Programmed death receptor 1 inhibitors are new therapeutic agents that produce clinical responses with a more manageable profile of adverse effects c
Autor:
María José Godes Sanz de Bremond, Carlos Camps Herrero, Joaquin Gavilá Gregori, Alfonso Berrocal Jaime, Ana Blasco Cordellat, Asunción Juárez Marroquí, Cristina Caballero Díaz, Maria Jose Safont Aguilera, Javier Garde Noguera, Vega Iranzo González-Cruz
Publikováno v:
Clinical and Translational Oncology. 7:278-284
La evolucion de los enfermos con cancer conduce en muchas ocasiones a fases de la enfermedad en las que no existen tratamientos especificos y estos debemos aplicarlos en la consecucion del maximo confort a traves de un adecuado control sintomatico, e
Autor:
Carlos, Camps Herrero, Joaquín, Gavilá Gregori, Javier, Garde Noguera, Cristina, Caballero Díaz, Vega, Iranzo González-Cruz, Asunción, Juárez Marroquí, Maria José, Safont Aguilera, Ana, Blasco Cordellat, Alfonso, Berrocal Jaime, Maria Godes, Sanz de Bremond
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(7)
During the clinical evolution of patients with cancer there are many occasions, or phases of the disease, when there are no specific treatments and, as such, we need to provide maximum comfort following appropriate symptom control; in this stage it i
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 29(3)
Autor:
Ana Albert Balaguer, Natividad Martínez Barracloche, Alfonso Berrocal Jaime, M.a José Safont Aguilera
Publikováno v:
Revista de Oncología. 3:319-320
We report a patient with chronic virus B and C hepatitis, who developed a fatal hepatic failure after chemotherapy suppression. A 56 years old man diagnosed of glioblastoma in treatment with cisplatin, procarbacin and UFT whose treatment was stopped